Literature DB >> 22640429

The horizon for treating cutaneous vascular lesions.

Amit M Patel1, Elizabeth L Chou, Laura Findeiss, Kristen M Kelly.   

Abstract

Dermatologists encounter a wide range of cutaneous vascular lesions, including infantile hemangiomas, port-wine stain birthmarks, arteriovenous malformations, venous malformations, Kaposi sarcomas, angiosarcomas, and angiofibromas. Current treatment modalities to reduce these lesions include topical and/or intralesional steroids, laser therapy, surgical resection, and endovascular therapy. However, each method has limitations owing to recurrence, comorbidities, toxicity, or lesion location. Photodynamic therapy, antiangiogenic therapy, and evolving methods of sclerotherapy are promising areas of development that may mitigate limitations of current treatments and offer exciting options for patients and their physicians.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22640429      PMCID: PMC3570568          DOI: 10.1016/j.sder.2012.02.001

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  33 in total

1.  Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.

Authors:  Anna K Haemel; Amy L O'Brian; Joyce M Teng
Journal:  Arch Dermatol       Date:  2010-07

2.  Partial response to bevacizumab of an extensive cutaneous angiosarcoma of the face.

Authors:  A Rosen; S Thimon; D Ternant; M C Machet; G Paintaud; L Machet
Journal:  Br J Dermatol       Date:  2010-04-12       Impact factor: 9.302

3.  Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial angiofibroma.

Authors:  R Salido; G Garnacho-Saucedo; I Cuevas-Asencio; J Ruano; M Galán-Gutierrez; A Vélez; J C Moreno-Giménez
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-08-11       Impact factor: 6.166

4.  Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies.

Authors:  Jennifer J Marler; Steven J Fishman; Susan M Kilroy; Jianmin Fang; Joseph Upton; John B Mulliken; Patricia E Burrows; David Zurakowski; Judah Folkman; Marsha A Moses
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

5.  Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod.

Authors:  Anne Marie Tremaine; Jennifer Armstrong; Yu-Chih Huang; Leila Elkeeb; Arisa Ortiz; Ronald Harris; Bernard Choi; Kristen M Kelly
Journal:  J Am Acad Dermatol       Date:  2012-01-14       Impact factor: 11.527

6.  Subcutaneous injection of normal saline prevents cutaneous complications of ethanol sclerotherapy for superficial vascular lesions: an experimental study.

Authors:  Aki Ihara; Masakazu Kurita; Mine Ozaki; Masahide Fujiki; Nobuyuki Kaji; Akihiko Takushima; Kiyonori Harii
Journal:  Dermatol Surg       Date:  2011-06-02       Impact factor: 3.398

7.  Activity of thalidomide in AIDS-related Kaposi's sarcoma.

Authors:  R F Little; K M Wyvill; J M Pluda; L Welles; V Marshall; W D Figg; F M Newcomb; G Tosato; E Feigal; S M Steinberg; D Whitby; J J Goedert; R Yarchoan
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

8.  Combined benzoporphyrin derivative monoacid ring photodynamic therapy and pulsed dye laser for port wine stain birthmarks.

Authors:  Joshua A Tournas; Jennifer Lai; Anne Truitt; Y C Huang; Kathryn E Osann; Bernard Choi; Kristen M Kelly
Journal:  Photodiagnosis Photodyn Ther       Date:  2009-11-12       Impact factor: 3.631

9.  The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.

Authors:  G F L Hofbauer; A Marcollo-Pini; A Corsenca; A D Kistler; L E French; R P Wüthrich; A L Serra
Journal:  Br J Dermatol       Date:  2008-06-28       Impact factor: 9.302

10.  Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies.

Authors:  Bridget F Koontz; Edward F Miles; Mary Ann D Rubio; John F Madden; Samuel R Fisher; Richard L Scher; David M Brizel
Journal:  Head Neck       Date:  2008-02       Impact factor: 3.147

View more
  1 in total

Review 1.  Lasers for cutaneous congenital vascular lesions: a comprehensive overview and update.

Authors:  Katlein França; Anna Chacon; Jennifer Ledon; Jessica Savas; Jan Izakovic; Keyvan Nouri
Journal:  Lasers Med Sci       Date:  2012-10-24       Impact factor: 3.161

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.